| __timestamp | HUTCHMED (China) Limited | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 105558000 |
| Thursday, January 1, 2015 | 67426000 | 167094000 |
| Friday, January 1, 2016 | 59752000 | 212608000 |
| Sunday, January 1, 2017 | 65383000 | 285920000 |
| Monday, January 1, 2018 | 70165000 | 322725000 |
| Tuesday, January 1, 2019 | 44738000 | 256174000 |
| Wednesday, January 1, 2020 | 39457000 | 208904000 |
| Friday, January 1, 2021 | 97894000 | 215332000 |
| Saturday, January 1, 2022 | 115306000 | 219525000 |
| Sunday, January 1, 2023 | 453552000 | 266843000 |
Cracking the code
In the ever-evolving landscape of the healthcare sector, understanding financial performance is crucial. This analysis delves into the gross profit trends of HUTCHMED (China) Limited and MiMedx Group, Inc. from 2014 to 2023. Over this period, MiMedx consistently outperformed HUTCHMED in terms of gross profit, with MiMedx's profits peaking in 2018 at approximately 322 million, a 50% increase from 2014. Meanwhile, HUTCHMED showed a remarkable growth trajectory, culminating in a staggering 353% increase in 2023 compared to its 2014 figures. This surge highlights HUTCHMED's strategic advancements in the market. Despite MiMedx's steady performance, HUTCHMED's recent growth spurt suggests a potential shift in market dynamics. Investors and stakeholders should keep a keen eye on these trends as they reflect broader industry shifts and company-specific strategies.
Who Generates Higher Gross Profit? AstraZeneca PLC or MiMedx Group, Inc.
Amgen Inc. and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Sanofi and HUTCHMED (China) Limited
Gross Profit Trends Compared: United Therapeutics Corporation vs MiMedx Group, Inc.
Key Insights on Gross Profit: Catalent, Inc. vs HUTCHMED (China) Limited
Catalent, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Halozyme Therapeutics, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Grifols, S.A. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Perrigo Company plc and HUTCHMED (China) Limited Trends
Gross Profit Comparison: MorphoSys AG and MiMedx Group, Inc. Trends
Gross Profit Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and MiMedx Group, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown